Barclays Initiates Coverage on Teladoc (TDOC) with Equal Weight at $8.50

Teladoc Health, Inc. (NYSE:TDOC) is one of the best healthcare AI stocks to buy now. On December 16, Teladoc Health, Inc. (NYSE:TDOC) disclosed that board director J. Eric Evans would retire in 2026. The company said Evans intended to not stand for reelection at the 2026 Annual Meeting of Stockholders. He will retire from the Board effective at the conclusion of that meeting.

Separately, on December 9, Barclays initiated coverage on Teladoc with an Equal Weight rating and an $8.50 price target. This debut note has a neutral stance on the state of the US healthcare technology and distribution industry.

Earlier on November 25, Bank of America Securities analyst Allen Lutz reiterated a Hold rating on Teladoc and lowered the price target to $8. Lutz said this update was a result of mixed results in user growth metrics. For instance, BetterHelp showed some sequential improvement in monthly active users (MAUs), yet faced a year-over-year decline. On the brighter side, Livongo’s MAUs hit their highest levels since early 2024. However, these figures are below 2022 peaks, meaning the rebound isn’t strong enough yet to fuel big revenue gains in the near term, stated Lutz.

Teladoc Health, Inc. (NYSE:TDOC) provides virtual healthcare services across general medical, chronic condition management, mental health, and specialty care. The company integrates AI-enabled features in its Virtual Sitter solution, which uses motion detection and pose estimation to identify patient movements that may precede falls.

While we acknowledge the potential of TDOC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 12 Best Consumer Goods Stocks Billionaires Are Quietly Buying and Goldman Sachs Penny Stocks: Top 12 Stock Picks.

Disclosure: None. This article is originally published at Insider Monkey.